Low-concentration homogenized castor oil eye drops for noninflamed obstructive meibomian gland dysfunction

Ophthalmology

Volumn 109, Issue 11, 2002, Pages 2030-2035

  Goto, Eiki ^a,b   Shimazaki, Jun ^a   Monden, Y u ^c   Takano, Yoji ^a,b   Yagi, Yukiko ^a   Shimmura, Shigeto ^a,b   Tsubota, Kazuo ^a  

^a TOKYO DENTAL COLLEGE   (Japan)

^b KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CASTOR OIL; EMULSIFYING AGENT; EYE DROPS; FLUORESCEIN; POLYOXYETHYLENE; ROSE BENGAL;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG FORMULATION; DRUG SAFETY; DRUG STABILITY; DRY EYE; EYE IRRITATION; EYELID DISEASE; FEMALE; HUMAN; MALE; MEIBOMIAN GLAND; OBSTRUCTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STAINING; SYMPTOMATOLOGY; TEAR FILM; VISUAL IMPAIRMENT;

CASTOR OIL; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; DRY EYE SYNDROMES; EMULSIONS; EYELID DISEASES; FEMALE; HUMANS; MALE; MEIBOMIAN GLANDS; MIDDLE AGED; OPHTHALMIC SOLUTIONS; PROSPECTIVE STUDIES; SAFETY; SURFACE-ACTIVE AGENTS; TREATMENT OUTCOME;

EID: 0036841406     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-6420(02)01262-9     Document Type: Article

References (29)

1. Mishima S, Maurice DM. The oily layer of the tear film and evaporation from the corneal surface. Exp Eye Res 1961;1:39-45.
2. Holly FJ. Tear film physiology. Am J Optom Physiol Opt 1980;57:252-7.
3. Tiffany JM. The role of meibomian secretion in the tears. Trans Ophthalmol Soc U K 1985;104:396-401.
4. Tiffany JM. The lipid secretion of the meibomian glands. Adv Lipid Res 1987;22:1-62.
5. Driver PJ, Lemp MA. Meibomian gland dysfunction. Surv Ophthalmol 1996;40:343-67.
6. Lemp MA. Report of the National Eye Institute/Industry Workshop on Clinical Trials in Dry Eyes. CLAO J 1995;21:221-32.
7. Shimazaki J, Sakata M, Tsubota K. Ocular surface changes and discomfort in patients with meibomian gland dysfunction. Arch Ophthalmol 1995;113:1266-70.
8. Lee SH, Tseng SCG. Rose bengal staining and cytologic characteristics associated with lipid tear deficiency. Am J Ophthalmol 1997;124:736-50.
9. Shimazaki J, Goto E, Ono M, et al. Meibomian gland dysfunction in patients with Sjögren syndrome. Ophthalmology 1998;105:1485-8.
10. Key JE. A comparative study of eyelid cleaning regimens in chronic blepharitis. CLAO J 1996;22:209-12.
11. Korb DR, Greiner JV. Increase in tear film lipid layer thickness following treatment of meibomian gland dysfunction. In: Sullivan DA, ed. Lacrimal Gland, Tear Film, and Dry Eye Syndromes. New York: Plenum Press, 1994;293-8.
12. Smith RE, Flowers CW Jr. Chronic blepharitis: A review. CLAO J 1995;21:200-7.
13. Rieger G. Lipid-containing eye drops: A step closer to natural tears. Ophthalmologica 1990;201:206-12.
14. Tiffany JM. Lipid-containing eye drops [letter]. Ophthalmologica 1991;203:47-9.
15. Japanese Pharmaceutical Excipients 1993. Tokyo: Yakuji Nippo, 1994;109.
16. Tsubota K, Goto E, Fujita H, et al. Treatment of dry eye by autologous serum application in Sjögren's syndrome. Br J Ophthalmol 1999;83:390-5.
17. Awata T. Stability of the eye drops. In: Ohashi Y, ed. The Eye Drops. Tokyo: Medical View Co, 1996;15-23.
18. Xu KP, Yagi Y, Toda I, Tsubota K. Tear function index. A new measure of dry eye. Arch Ophthalmol 1995;113:84-8.
19. Fox RI, Robinson CA, Curd JG, et al. Sjögren's syndrome. Proposed criteria for classification. Arthritis Rheum 1986;29:577-85.
20. Robin JB, Jester JV, Nobe J, et al. In vivo transillumination biomicroscopy and photography of meibomian gland dysfunction. A clinical study. Ophthalmology 1985;92:1423-6.
21. Yokoi N, Takehisa Y, Kinoshita S. Correlation of tear lipid layer interference patterns with the diagnosis and severity of dry eye. Am J Ophthalmol 1996;122:818-24.
22. Yokoi N, Mossa F, Tiffany JM, Bron AJ. Assessment of meibomian gland function in dry eye using meibometry. Arch Ophthalmol 1999;117:723-9.
23. Tsubota K, Yamada M. Tear evaporation from the ocular surface. Invest Ophthalmol Vis Sci 1992;33:2942-50.
24. Toda I, Tsubota K. Practical double vital staining for ocular surface evaluation [letter]. Cornea 1993;12:366-7.
25. van Bijsterveld OP. Diagnostic tests in the sicca syndrome. Arch Ophthalmol 1969;82:10-4.
26. Rulo AH, Greve EL, Geijssen HC, Hoyng PFJ. Reduction of intraocular pressure with treatment of latanoprost once daily in patients with normal-pressure glaucoma. Ophthalmology 1996;103:1276-82.
27. Mitsui T. Physiochemistry of the Cosmetics. 1st Ed. Tokyo: Nanzando, 1993;128-56.
28. Nagai K. Polyoxyethylene castor oil derivatives. In: Saito Y, ed. Handbook of Pharmaceutical Excipients, Japanese Edition. Tokyo: The Pharmaceutical Society of Japan, 1986;345-8.
29. Korb DR, Baron DF, Herman JP, et al. Tear film lipid layer thickness as a function of blinking. Cornea 1994;13:354-9.